Page last updated: 2024-08-23

taurolidine and Neoplasms

taurolidine has been researched along with Neoplasms in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's5 (45.45)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Fiocco, M; Frakking, FNJ; Loeffen, Y; van de Ven, CP; van de Wetering, MD; van den Bosch, CH; van der Bruggen, JT; van der Steeg, AFW; Wijnen, MHWA1
Bottos, P; Brescia, F; Da Ros, V; Fabiani, F; Moreal, C; Nadalini, E; Pittiruti, M; Scoppettuolo, G; Zanier, C1
Eid, N; Goetz, C; Llorens, M; Longo, R; Ouamara, N; Platini, C; Quétin, P; Sellies, J1
Handrup, MM; Møller, JK; Schrøder, H1
Frei, K; Möhler, H; Pfirrmann, RW1
Ammann, RA; Besuden, MM; Bode, U; Fleischhack, G; Simon, A; Wiszniewsky, G1
Bouchier-Hayes, DJ; Hallihan, P; Neary, PM; Pfirrmann, RW; Redmond, HP; Wang, JH1
Bulut, D; Chromik, AM; Daigeler, A; Flier, A; Hahn, SA; Harati, K; May, C; Mittelkötter, U; Ritter, PR; Roschinsky, J; Sülberg, D; Uhl, W1
Koldehoff, M; Zakrzewski, JL1
Braumann, C; Jacobi, CA; Menenakos, C1
Braumann, C; Dubiel, W; Jacobi, CA; Müller, JM; Tangermann, J1

Reviews

4 review(s) available for taurolidine and Neoplasms

ArticleYear
Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review).
    International journal of oncology, 2014, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Dioxolanes; Humans; Neoplasms; Oxidation-Reduction; Perioperative Care; Reactive Oxygen Species; Taurine; Thiadiazines

2014
The evolving role of taurolidine in cancer therapy.
    Annals of surgical oncology, 2010, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Taurine; Thiadiazines

2010
Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Cytokines; Humans; Models, Animal; Neoplasms; Protein Biosynthesis; Taurine; Thiadiazines; Vascular Endothelial Growth Factor A

2005
Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets.
    Mini reviews in medicinal chemistry, 2008, Volume: 8, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; COP9 Signalosome Complex; Curcumin; Drug Screening Assays, Antitumor; Emodin; Humans; Models, Molecular; Multiprotein Complexes; Neoplasms; Peptide Hydrolases; Protein Kinase Inhibitors; Structure-Activity Relationship; Taurine; Thiadiazines

2008

Trials

4 trial(s) available for taurolidine and Neoplasms

ArticleYear
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
    BMJ open, 2023, 03-21, Volume: 13, Issue:3

    Topics: Catheter-Related Infections; Central Venous Catheters; Child; Citrates; Citric Acid; Heparin; Humans; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Sepsis

2023
Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Oncology, 2017, Volume: 93, Issue:2

    Topics: Aged; Anti-Infective Agents; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Central Venous Catheters; Female; Humans; Incidence; Male; Middle Aged; Neoplasms; Primary Prevention; Prospective Studies; Taurine; Thiadiazines; Treatment Outcome

2017
Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:8

    Topics: Adolescent; Adult; Anti-Infective Agents; Anticoagulants; Central Venous Catheters; Child; Child, Preschool; Female; Heparin; Humans; Infant; Infant, Newborn; Infection Control; Infections; Male; Neoplasms; Prospective Studies; Taurine; Thiadiazines

2013
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    International journal of antimicrobial agents, 2004, Volume: 24, Issue:5

    Topics: Adult; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Female; Humans; Male; Neoplasms; Pilot Projects; Prosthesis-Related Infections; Solutions; Taurine; Thiadiazines; Treatment Outcome

2004

Other Studies

3 other study(ies) available for taurolidine and Neoplasms

ArticleYear
Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
    The journal of vascular access, 2023, Volume: 24, Issue:1

    Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Humans; Neoplasms; Retrospective Studies; Sepsis; Taurine; Thiadiazines

2023
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients.
    BMC infectious diseases, 2008, Jul-29, Volume: 8

    Topics: Adolescent; Adult; Anti-Infective Agents; Catheterization, Central Venous; Child; Child, Preschool; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Neoplasms; Prospective Studies; Taurine; Thiadiazines

2008
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
    Journal of experimental & clinical cancer research : CR, 2010, Mar-07, Volume: 29

    Topics: Acetylcysteine; Antineoplastic Agents; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutathione; Humans; Neoplasms; Reactive Oxygen Species; Taurine; Thiadiazines

2010